Diet, physical exercise and Orlistat administration increase serum Anti-Mullerian Hormone (AMH) levels in women with polycystic ovary syndrome (PCOS)

被引:32
作者
Vosnakis, Christos [1 ]
Georgopoulos, Neoklis A. [2 ]
Rousso, David [1 ]
Mavromatidis, Georgios [1 ]
Katsikis, Ilias [3 ]
Roupas, Nikolaos D. [2 ]
Mamali, Irene [2 ]
Panidis, Dimitrios [3 ]
机构
[1] Aristotle Univ Thessaloniki, Dept Obstet & Gynecol 3, GR-54006 Thessaloniki, Greece
[2] Univ Patras, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol, Patras 26500, Greece
[3] Aristotle Univ Thessaloniki, Dept Obstet & Gynecol 2, Div Endocrinol & Human Reprod, GR-54006 Thessaloniki, Greece
关键词
Anti-Mullerian Hormone; LH; insulin resistance; Orlistat; PCOS; INHIBITING SUBSTANCE LEVELS; LUTEINIZING-HORMONE; INSULIN-RESISTANCE; MOUSE OVARY; LEAN WOMEN; OBESITY; GROWTH; ASSOCIATION; GHRELIN; FSH;
D O I
10.3109/09513590.2012.736557
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study investigates the combined effect of diet, physical exercise and Orlistat for 24 weeks, on serum Anti-Mullerian Hormone (AMH) levels in overweight and obese women with polycystic ovary syndrome (PCOS) and in overweight and obese controls. Sixty-one (61) selected women with PCOS and 20 overweight and obese controls followed an energy-restricted diet, physical exercise plus Orlistat administration (120 mg, 3 times per day) for 24 weeks. At baseline, week 12 and week 24, serum levels of AMH, FSH, LH, PRL, androgens, sex hormone-binding globulin (SHBG), glucose, and insulin were measured and Free Androgen Index (FAI) and Insulin Resistance (IR) indices were calculated. In PCOS women, serum AMH levels increased after 12 and 24 weeks of treatment. After 12 weeks LH and SHBG were increased, while Testosterone decreased. After 12 and 24 weeks, FAI was decreased and all indices of IR were significantly improved. We concluded that in overweight and obese women with PCOS Orlistat administration, combined with diet and physical exercise, for 24 weeks, resulted in significant weight loss, improvement of hyperandrogenism and insulin sensitivity, and increased serum AMH levels.
引用
收藏
页码:242 / 245
页数:4
相关论文
共 50 条
  • [21] Role of anti-Mullerian hormone in polycystic ovary syndrome
    Koushik Bhattacharya
    Ishita Saha
    Debanjana Sen
    Chaitali Bose
    Gargi Ray Chaudhuri
    Sulagna Dutta
    Pallav Sengupta
    Soumita Bhattacharya
    Sharit Shekhar Barman
    Alak Kumar Syamal
    Middle East Fertility Society Journal, 27
  • [22] The relationship between serum anti-Mullerian hormone levels and the follicular arrest for women with polycystic ovary syndrome
    Li, Jian
    Li, Rong
    Yu, Hua
    Zhao, Shuyun
    Yu, Yang
    Qiao, Jie
    SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE, 2015, 61 (02) : 103 - 109
  • [23] Serum Anti-Mullerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms
    Ahmed, Nada
    Batarfi, Asma A.
    Bajouh, Osama S.
    Bakhashab, Sherin
    DIAGNOSTICS, 2019, 9 (04)
  • [24] Efficacy of serum anti-mullerian hormone (AMH) levels for prediction of polycystic ovary syndrome (PCOS) and its association with clinical, biochemical and hormonal parameters
    Sumji, Sajad
    Bhat, Abid
    Rashid, Aafia
    Bashir, Rohina
    Wani, Imtiyaz A.
    Vasudevan, Vishnu
    Sehar, Tajali
    Ganie, Mohd Ashraf
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2023, 38 (04) : 457 - 465
  • [25] Effects of Raloxifene and their Combination with Pioglitazone on Serum Anti-Mullerian Hormone Levels in Patients with Resistance Polycystic Ovary Syndrome
    Kutaif, Rana Hussein
    Alabbassi, Mustafa G.
    Hussein, Weqar Akram
    Aldujaili, Alla Abdul-Mehdi
    Ali, Zainab Faleh
    Jassim, Shatha Khayun
    LATIN AMERICAN JOURNAL OF PHARMACY, 2021, 40 (SI): : 76 - 81
  • [26] The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary Syndrome
    Sivanandy, Mala S.
    Ha, Sierra K.
    DIAGNOSTICS, 2023, 13 (05)
  • [27] The impact of oral contraceptives and metformin on anti-Mullerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia
    Panidis, Dimitrios
    Georgopoulos, Neoklis A.
    Piouka, Athanasia
    Katsikis, Ilias
    Saltamavros, Alexandros D.
    Decavalas, George
    Diamanti-Kandarakis, Evanthia
    GYNECOLOGICAL ENDOCRINOLOGY, 2011, 27 (08) : 587 - 592
  • [28] Anti-Mullerian hormone (AMH) as a useful marker in diagnosis of polycystic ovary syndrome
    Leonte, Laura
    Coculescu, M.
    Radian, S.
    Fica, Simona
    Caragheorgheopol, Andra
    Marinescu, B.
    Bohaltea, L. C.
    Grigorescu, F.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2007, 3 (01) : 1 - 11
  • [29] Response to ovulation induction treatments in women with polycystic ovary syndrome as a function of serum anti-Mullerian hormone levels
    Vagios, Stylianos
    Sacha, Caitlin R.
    Hammer, Karissa C.
    Dimitriadis, Irene
    James, Kaitlyn E.
    Bormann, Charles L.
    Souter, Irene
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2021, 38 (07) : 1827 - 1833
  • [30] Serum Anti-Mullerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum Follicle Stimulating Hormone (FSH) levels
    Panidis, Dimitrios
    Katsikis, Ilias
    Karkanaki, Artemis
    Piouka, Athanasia
    Armeni, Anastasia K.
    Georgopoulos, Neoklis A.
    MEDICAL HYPOTHESES, 2011, 77 (04) : 649 - 653